Cargando…
Concurrent Chemoradiation With 5-Fluorouracil and Mitomycin in Squamous Cell Carcinoma of the Rectum
Rectal carcinoma-squamous type is infrequently seen. Etiopathogenesis, prognosis, and therapeutic management of rectal squamous cell carcinoma (SCC) are not clearly defined. Rectal SCC is now approached with definitive upfront chemoradiotherapy (CRT), with 5-fluorouracil (5-FU) and mitomycin with a...
Autor principal: | Sethi, Ashish K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476189/ https://www.ncbi.nlm.nih.gov/pubmed/34603888 http://dx.doi.org/10.7759/cureus.17518 |
Ejemplares similares
-
Human Papillomavirus Positive Squamous Cell Carcinoma of the Rectum
por: Makadia, Shraddhadevi, et al.
Publicado: (2020) -
Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal
por: Saint, Angélique, et al.
Publicado: (2019) -
Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
por: Thind, Govin, et al.
Publicado: (2014) -
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10–2 trial)
por: Murofushi, Keiko Nemoto, et al.
Publicado: (2022) -
Chemoradiation therapy with S-1 for primary squamous cell carcinoma of the rectum: report of three cases
por: Funahashi, Kimihiko, et al.
Publicado: (2015)